Enteric fever in Israeli travelers: A nationwide study

Journal of Travel Medicine

Volumn 12, Issue 5, 2005, Pages 275-281

  Meltzer, Eyal ^a,b   Sadik, Chantai ^c   Schwartz, Eli ^a,b  

^a SHEBA MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c MINISTRY OF HEALTH   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

TYPHOID VACCINE; TYPHRIX;

ADULT; ARTICLE; BLOOD CULTURE; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; IMMUNIZATION; INCIDENCE; ISRAEL; MAJOR CLINICAL STUDY; MALE; NONHUMAN; RELAPSE; SALMONELLA PARATYPHI; SALMONELLA TYPHI; SEROTYPE; TRAVEL; TREATMENT OUTCOME; TYPHOID FEVER; VACCINATION;

EID: 30444449038     PISSN: 11951982     EISSN: None     Source Type: Journal    
DOI: 10.2310/7060.2005.12507     Document Type: Article

References (26)

1. Parry CM, Hien TT, Dougan G, et al. Typhoid fever. N Engl J Med 2002; 347:1770-1782.
2. Tulchinsky TH, Burla E, Clayman M, et al. Safety of community drinking-water and outbreaks of waterborne enteric disease: Israel, 1976-97. Bull World Health Organ 2000; 78:1466-1473.
3. Engels EA, Lau J. Vaccines for preventing typhoid fever. Cochrane Database Syst Rev 2000; 2:CD001261.
4. Schwartz E, Shlim DR. Enteric fever among Israeli travelers in Nepal: the need for typhoid vaccination. Isr J Med Sci 1990; 26:325-327.
5. Schwartz E, Shlim DR, Eaton M, et al. The effect of oral and parenteral typhoid vaccination on the rate of infection with Salmonella typhi and Salmonella paratyphi A among foreigners in Nepal. Arch Intern Med 1990; 150:349-351.
6. Cobelens FG, Kooij S, Warris-Versteegen A, Visser LG. Typhoid fever in group travelers: opportunity for studying vaccine efficacy. J Travel Med 2000; 7:19-24.
7. Shlim DR, Schwartz E, Eaton M. Clinical importance of Salmonella paratyphi A infection to enteric fever in Nepal. J Travel Med 1995; 2:165-168.
8. Rodrigues C, Shenai S, Mehta A. Enteric fever in Mumbai, India: the good news and the bad news. Clin Infect Dis 2003; 36:535.
9. Montes M, DuPont HL. Enteritis, enterocolitis and infectious diarrhea syndromes. In: Cohen J, Powderly WJ, eds. Cohen & Powderly: infectious diseases. 2nd Ed. Edinburgh: Mosby, 2004:477-490.
10. Kaye KS, Kaye D. Salmonella infections other than typhoid fever. In: Goldman L, ed. Cecil textbook of medicine. 22nd Ed. Philadelphia: W. B. Saunders Company, 2004:1851-1852.
11. Black RE, Levine MM, Ferreccio C, et al. Efficacy of one or two doses of Ty21a Salmonella typhi vaccine in enteric-coated capsules in a controlled field trial. Chilean Typhoid Committee. Vaccine 1990; 8:81-84.
12. Simanjuntak CH, Paleologo FP, Punjabi NH, et al. Oral immunisation against typhoid fever in Indonesia with Ty21a vaccine. Lancet 1991; 338:1055-1059.
13. Lin FY, Ho VA, Khiem HB, et al. The efficacy of a Salmonella typhi Vi conjugate vaccine in two-to-five-year-old children. N Engl J Med 2001; 344:1263-1269.
14. Tacket CO, Pasetti MF, Sztein MB, et al. Immune responses to an oral typhoid vaccine strain that is modified to constitutively expressVi capsular polysaccharide. J Infect Dis 2004; 190:565-570.
15. Mermin JH, Townes JM, Gerber M, et al. Typhoid fever in the United States, 1985-1994: changing risks of international travel and increasing antimicrobial resistance. Arch Intern Med 1998; 158:633-638.
16. Lester A, Mygind O, Jensen KT, et al. Typhoid and paratyphoid fever in Denmark 1986-1990. Epidemiologic aspects and the extent of bacteriological follow-up of patients. Ugeskr Laeger 1994; 156:3770-3775.
17. Braddick MR, Sharp JC. Enteric fever in Scotland 1975-1990. Pub Health 1993; 107:193-198.
18. Caumes E, Ehya N, Nguyen J, Bricaire F. Typhoid and paratyphoid fever: a 10-year retrospective study of 41 cases in a Parisian hospital. J Travel Med 2001; 8:293-297.
19. Hoshino Y, Masuda G, Negishi M, et al. Clinical and bacteriological profiles of patients with typhoid fever treated during 1975-1998 in the Tokyo Metropolitan Komagome Hospital. Microbiol Immunol 2000; 44:577-583.
20. Sinha A, Sazawal S, Kumar R, et al. Typhoid fever in children aged less than 5 years. Lancet 1999; 354:734-737.
21. World Health Organization. Background document: the diagnosis, treatment and prevention of typhoid fever. Geneva: WHO, 2003.
22. Bacaner N, Stauffer B, Boulware DR, et al. Travel medicine considerations for North American immigrants visiting friends and relatives. JAMA 2004; 291:2856-2864.
23. Meltzer E, Yossepowitch O, Sadik C, et al. Epidemiology and clinical aspects of enteric fever in Israel. Am J Trop Med Hyg. (In press)
24. Crump JA, Youssef FG, Luby SP, et al. Estimating the incidence of typhoid fever and other febrile illnesses in developing countries. Emerg Infect Dis 2003; 9:539-544.
25. Ministry of Public Health Thailand. Annual Epidemiological Surveillance Report. 2004; [3 screens]. Available at: http://epid.moph.go.th/Annual47/ annual47_index_2.html (accessed Sept. 19, 2005).
26. Acharya IL, Lowe CU, Thapa R, et al. Prevention of typhoid fever in Nepal with the Vi capsular polysaccharide of Salmonella typhi. A preliminary report. N Engl J Med 1987; 317:1101-1104.